Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended December 2024. While this widely-known consensus outlook ...

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

We combine progressive healthcare education and patient care with world-class research and outstanding teaching facilities in order to help you to become the very best doctor you can be. But don't ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Request To Download Free Sample of This Strategic Report @ Driving Forces Behind Growth: The exponential growth of the North America medical implant market is propelled by several key drivers.

Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The unprecedented growth of the medical implant market is propelled by several key factors. Firstly, the aging ...

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a research note issued on Monday, January 27th. Roth Capital analyst J. Wittes ...